Detection of skewed T-cell receptor V-β gene usage in the peripheral blood of patients with multiple sclerosis

Journal of Neuroimmunology

Volumn 85, Issue 1, 1998, Pages 22-32

  Gran, Bruno ^a   Gestri, Donella ^a   Sottini, Alessandra ^b   Quiròs Roldàn, Eugenia ^b   Bettinardi, Alessandra ^b   Signorini, Simona ^c   Primi, Daniele ^b   Ballerini, Clara ^a   Taiuti, Rosanna ^a   Amaducci, Luigi ^a   Massacesi, Luca ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b P le Spedali Civili 1 ^*  (Italy)

^c III Laboratorio Analisi   (Italy)

Author keywords

Disease duration; Multiple sclerosis; T cell receptor repertoire

Indexed keywords

T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MULTIGENE FAMILY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE RECEPTOR GENE; T LYMPHOCYTE SUBPOPULATION;

ADULT; AMINO ACID SEQUENCE; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOGENETICS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MONOCYTES; MULTIPLE SCLEROSIS; NUCLEIC ACID HETERODUPLEXES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REFERENCE VALUES;

EID: 0032077869     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00250-6     Document Type: Article

References (46)

1. Acha-Orbea H., Mitchell D.J., Timmermann L., Wraith D.C., Tausch G.S., Waldor M.K., Zamvil S.S., McDevitt H.O., Steinman L. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell. 54:1988;263-273.
2. Akolkar P.N., Gulwani-Akolkar B., Pergolizzi R., Bigler R.D., Silver J. Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes. J. Immunol. 150:1993;2761-2773.
3. Allegretta M., Albertini R.J., Howell M.D., Smith L.R., Martin R., McFarland H.F., Sriram S., Brostoff S., Steinman L. Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitis. J. Clin. Invest. 94:1994;105-109.
4. Angelini G., Bugawan T.L., Delfino L., Erlich H.A., Ferrara G.B. HLA-DP typing by DNA amplification and hybridization with specific oligonucleotides. Hum. Immunol. 26:1989;169-177.
5. Bettinardi A., Imberti L., Sottini A., Primi D. Analysis of amplified T cell receptor V beta transcripts by a non-isotopic immunoassay. J. Immunol. Methods. 146:1992;71-82.
6. Birnbaum G., van Ness B. Quantitation of T-cell receptor V beta chain expression on lymphocytes from blood, brain, and spinal fluid in patients with multiple sclerosis and other neurological diseases. Ann. Neurol. 32:1992;24-30.
7. Boitel B., Ermonval M., Panina-Bordignon P., Mariuzza R.A., Lanzavecchia A., Acuto O. Preferential V beta gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin-derived peptide: evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility complex recognition. J. Exp. Med. 175:1992;765-777.
8. Brocke S., Gaur A., Piercy C., Gautam A., Gijbels K., Fathman C.G., Steinman L. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature. 365:1993;642-644.
9. Choi Y.W., Kotzin B., Herron L., Callahan J., Marrack P., Kappler J. Interaction of Staphylococcus aureus toxin 'superantigens' with human T cells. Proc. Natl. Acad. Sci. U.S.A. 86:1989;8941-8945.
10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
11. Currier J.R., Deulofeut H., Barron K.S., Kehn P.J., Robinson M.A. Mitogens, superantigens, and nominal antigens elicit distinctive patterns of TCRB CDR3 diversity. Hum. Immunol. 48:1996;39-51.
12. Davis M.M., Bjorkman P.J. T-cell antigen receptor genes and T-cell recognition. Nature. 334:1988;395-402.
13. Ferradini L., Roman-Roman S., Azocar J., Michalaki H., Triebel F., Hercend T. Studies on the human T cell receptor alpha/beta variable region genes: II. Identification of four additional V beta subfamilies. Eur. J. Immunol. 21:1991;935-942.
14. Fitzgerald J.E., Ricalton N.S., Meyer A.C., West S.G., Kaplan H., Behrendt C., Kotzin B.L. Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis. J. Immunol. 154:1995;3538-3547.
15. Goverman J., Woods A., Larson L., Weiner L.P., Hood L., Zaller D.M. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell. 72:1993;551-560.
16. Hafler D.A., Saadeh M.G., Kuchroo V.K., Milford E., Steinman L. TCR usage in human and experimental demyelinating disease. Immunol. Today. 17:1996;152-159.
17. Hawes G.E., Struyk L., Godthelp B.C., van den Elsen P.J. Limited restriction in the TCR-alpha beta V region usage of antigen-specific clones. Recognition of myelin basic protein (amino acids 84-102) and Mycobacterium bovis 65-kDa heat shock protein (amino acids 3-13) by T cell clones established from peripheral blood mononuclear cells of monozygotic twins and HLA-identical individuals. J. Immunol. 154:1995;555-566.
18. Jason J., Inge K.L. The effects of mitogens, IL-2 and anti-CD3 antibody on the T-cell receptor V beta repertoire. Scand. J. Immunol. 43:1996;652-661.
19. Kimura, A., Sasazuki, T., 1992. XI International Histocompatibility Workshop reference protocol for the HLA DNA typing technique. In: Tsui, K., Aizowa, M., Sasazuki, T. (Eds.), HLA 1991, Proceedings of the 11th International Histocompatibility Workshop and Conference, Vol. 1. Oxford Univ. Press, New York, pp. 397-419.
20. Kimura N., Toyonaga B., Yoshikai Y., Triebel F., Debre P., Minden M.D., Mak T.W. Sequences and diversity of human T cell receptor beta chain variable region genes. J. Exp. Med. 164:1986;739-750.
21. Kimura N., Toyonaga B., Yoshikai Y., Du R.P., Mak T.W. Sequences and repertoire of the human T cell receptor alpha and beta chain variable region genes in thymocytes. Eur. J. Immunol. 17:1987;75-383.
22. Kotzin B.L., Karuturi S., Chou Y.K., Lafferty J., Forrester J.M., Better M., Nedwin G.E., Offner H., Vandenbark A.A. Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 88:1991;9161-9165.
23. Kotzin B.L., Leung D.Y., Kappler J., Marrack P. Superantigens and their potential role in human disease. Adv. Immunol. 54:1993;99-166.
24. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33:1983;1444-1452.
25. Lodge P.A., Allegretta M., Steinman L., Sriram S. Myelin basic protein peptide specificity and T-cell receptor gene usage of HPRT mutant T-cell clones in patients with multiple sclerosis. Ann. Neurol. 36:1994;734-740.
26. Lublin F.D., Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology. 46:1996;907-911.
27. Martin R., McFarland H.F. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 32:1995;121-182.
28. Martin R., Howell M.D., Jaraquemada D., Flerlage M., Richert J., Brostoff S., Long E.O., McFarlin D.E., McFarland H.F. A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J. Exp. Med. 173:1991;19-24.
29. Meinl E., Weber F., Drexler K., Morelle C., Ott M., Saruhan-Direskeneli G., Goebels N., Ertl B., Jechart G., Giegerich G.et al. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones. J. Clin. Invest. 92:1993;2633-2643.
30. Moss, P.A.H., Bell, J.I., 1995. The human T cell receptor repertoire. In: Bell, J.I., Owen, M.J., Simpson, E. (Eds.), T Cell Receptors, Oxford Univ. Press, Oxford, pp. 111-132.
31. Oksenberg J.R., Panzara M.A., Begovich A.B., Mitchell D., Erlich H.A., Murray R.S., Shimonkevitz R., Sherritt M., Rothbard J., Bernard C.C.et al. Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature. 362:1993;68-70.
32. Oldstone M.B. Molecular mimicry and autoimmune disease. Cell. 50:1987;819-820.
33. Panitch H.S. Influence of infection on exacerbations of multiple sclerosis. Ann. Neurol. 36:1994;S25-28. Suppl.
34. Poser C.M. Onset symptoms of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 58:1995;253-254.
35. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
36. Prineas, J.W., 1985. The neuropathology of multiple sclerosis. In: Vinken, P.J., Bruyn, G.W., Klawans, H.L., Koetsier, J.C. (Eds.), Handbook of Clinical Neurology. Demyelinating Diseases, Vol. 3. Elsevier, Amsterdam, pp. 213-257.
37. Richert J.R., Robinson E.D., Camphausen K., Hastings E., Martin R., Voskuhl R., McFarland H.F. T-cell receptor alpha and beta CDR3 expression by myelin basic protein-specific human T-cell clones. Ann. NY Acad. Sci. 756:1995;317-318.
38. Shanmugam A., Copie-Bergman C., Falissard B., Delrieu O., Jais J.P., Rebibo D., Bach J.F., Tournier-Lasserve E. TCR alpha beta gene usage for myelin basic protein recognition in healthy monozygous twins. J. Immunol. 156:1996;3747-3754.
39. Sottini A., Quiros-Roldan E., Albertini A., Primi D., Imberti L. Assessment of T-cell receptor beta-chain diversity by heteroduplex analysis. Hum. Immunol. 48:1996;12-22.
40. Steinman, L., 1994. Specific motifs in T cell receptor V beta D beta J beta gene sequences in multiple sclerosis lesions in brain. Behring Inst. Mitt., pp. 148-157.
41. Thompson A.J., Kermode A.G., Wicks D., MacManus D.G., Kendall B.E., Kingsley D.P., McDonald W.I. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann. Neurol. 29:1991;53-62.
42. Vandenbark A.A., Hashim G., Offner H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature. 341:1989;541-544.
43. Vandevyver C., Mertens N., van den Elsen P., Medaer R., Raus J., Zhang J. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur. J. Immunol. 25:1995;958-968.
44. Wucherpfennig K.W., Ota K., Endo N., Seidman J.G., Rosenzweig A., Weiner H.L., Hafler D.A. Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. Science. 248:1990;1016-1019.
45. Wucherpfennig K.W., Newcombe J., Li H., Keddy C., Cuzner M.L., Hafler D.A. Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions. Proc. Natl. Acad. Sci. U.S.A. 89:1992;4588-4592.
46. Wucherpfennig K.W., Zhang J., Witek C., Matsui M., Modabber Y., Ota K., Hafler D.A. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J. Immunol. 152:1994;5581-5592.